Eligibility Chronic Kidney Disease NCT00308971

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients with stage iii-iv chronic kidney disease measured by mdrd formula.
Descrição

chronic kidney disease stage by mdrd formula

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1561643
UMLS CUI [1,2]
C2074731
UMLS CUI [1,3]
C1980036
2. age > 18 or < 75 years.
Descrição

age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
3. life expectancy greater than one year.
Descrição

life expectancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0023671
4. ability to understand and provide informed consent for participation in the study
Descrição

informed consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. aids (hiv seropositivity is not an exclusion criteria)
Descrição

aids

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001175
2. active hepatitis c or b
Descrição

hepatitis b or c

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
3. active gout
Descrição

gout

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0018099
4. other active inflammatory diseases.
Descrição

inflammatory disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1290884
5. active malignancy excluding basal or squamous cell carcinoma of the skin.
Descrição

malignancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0006826
6. gastrointestinal dysfunction requiring parental nutrition.
Descrição

gastrointestinal dysfunction requiring parenteral nutrition

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0679407
UMLS CUI [1,2]
C0030547
7. history of functional kidney transplant < 6 months prior to study entry.
Descrição

kidney transplant

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0022671
8. anticipated live donor kidney transplant over study duration.
Descrição

kidney transplant anticipated

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0022671
UMLS CUI [1,2]
C3840775
9. prisoners, patients will significant mental illness, pregnant women, and other vulnerable populations.
Descrição

prisoner, mental illness, pregnancy, vulnerable populations

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0033167
UMLS CUI [2]
C0004936
UMLS CUI [3]
C0032961
UMLS CUI [4]
C0949366
10. patients taking vitamin e supplements > 60 iu/day, vitamin c> 500mg/day over the past 30days.
Descrição

vitamin e/c supplements

Tipo de dados

boolean

Alias
UMLS CUI [1]
C3661607
UMLS CUI [2]
C3661608
11. patients taking anti-inflammatory medication except aspirin < 325mg/day over the past 30 days.
Descrição

anti-inflammatory medication

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0003209
UMLS CUI [2]
C0004057
12. patient taking any prednisone therapy.
Descrição

prednisone

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032952
13. more than two hospitalizations within the last 90 days or one hospitalization within the last 30 days.
Descrição

hospitalizations

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0019993
14. on experimental drug protocols.
Descrição

experimental drug

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0304229
15. hypersensitivity to organic nitrates, isosorbide, or nitroglycerin.
Descrição

hypersensitivity to organic nitrates, isosorbide, nitroglycerin

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3654024
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0022251
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0017887
16. hypersensitivity to vitamin e or alpha lipoic acid.
Descrição

hypersensitivity to vitamin e or alpha lipoic scid

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0042874
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0023791
17. pregnant women
Descrição

pregnancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961

Similar models

Eligibility Chronic Kidney Disease NCT00308971

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
chronic kidney disease stage by mdrd formula
Item
1. patients with stage iii-iv chronic kidney disease measured by mdrd formula.
boolean
C1561643 (UMLS CUI [1,1])
C2074731 (UMLS CUI [1,2])
C1980036 (UMLS CUI [1,3])
age
Item
2. age > 18 or < 75 years.
boolean
C0001779 (UMLS CUI [1])
life expectancy
Item
3. life expectancy greater than one year.
boolean
C0023671 (UMLS CUI [1])
informed consent
Item
4. ability to understand and provide informed consent for participation in the study
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
aids
Item
1. aids (hiv seropositivity is not an exclusion criteria)
boolean
C0001175 (UMLS CUI [1])
hepatitis b or c
Item
2. active hepatitis c or b
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
gout
Item
3. active gout
boolean
C0018099 (UMLS CUI [1])
inflammatory disease
Item
4. other active inflammatory diseases.
boolean
C1290884 (UMLS CUI [1])
malignancy
Item
5. active malignancy excluding basal or squamous cell carcinoma of the skin.
boolean
C0006826 (UMLS CUI [1])
gastrointestinal dysfunction requiring parenteral nutrition
Item
6. gastrointestinal dysfunction requiring parental nutrition.
boolean
C0679407 (UMLS CUI [1,1])
C0030547 (UMLS CUI [1,2])
kidney transplant
Item
7. history of functional kidney transplant < 6 months prior to study entry.
boolean
C0022671 (UMLS CUI [1])
kidney transplant anticipated
Item
8. anticipated live donor kidney transplant over study duration.
boolean
C0022671 (UMLS CUI [1,1])
C3840775 (UMLS CUI [1,2])
prisoner, mental illness, pregnancy, vulnerable populations
Item
9. prisoners, patients will significant mental illness, pregnant women, and other vulnerable populations.
boolean
C0033167 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
C0032961 (UMLS CUI [3])
C0949366 (UMLS CUI [4])
vitamin e/c supplements
Item
10. patients taking vitamin e supplements > 60 iu/day, vitamin c> 500mg/day over the past 30days.
boolean
C3661607 (UMLS CUI [1])
C3661608 (UMLS CUI [2])
anti-inflammatory medication
Item
11. patients taking anti-inflammatory medication except aspirin < 325mg/day over the past 30 days.
boolean
C0003209 (UMLS CUI [1])
C0004057 (UMLS CUI [2])
prednisone
Item
12. patient taking any prednisone therapy.
boolean
C0032952 (UMLS CUI [1])
hospitalizations
Item
13. more than two hospitalizations within the last 90 days or one hospitalization within the last 30 days.
boolean
C0019993 (UMLS CUI [1])
experimental drug
Item
14. on experimental drug protocols.
boolean
C0304229 (UMLS CUI [1])
hypersensitivity to organic nitrates, isosorbide, nitroglycerin
Item
15. hypersensitivity to organic nitrates, isosorbide, or nitroglycerin.
boolean
C0020517 (UMLS CUI [1,1])
C3654024 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0022251 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0017887 (UMLS CUI [3,2])
hypersensitivity to vitamin e or alpha lipoic scid
Item
16. hypersensitivity to vitamin e or alpha lipoic acid.
boolean
C0020517 (UMLS CUI [1,1])
C0042874 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0023791 (UMLS CUI [2,2])
pregnancy
Item
17. pregnant women
boolean
C0032961 (UMLS CUI [1])